The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
1998
DOI: 10.1093/nar/26.14.3379
|View full text |Cite
|
Sign up to set email alerts
|

Allosteric regulation of a ribozyme activity through ligand-induced conformational change

Abstract: An allosteric ribozyme has been designed using the hammerhead ribozyme as the active site and aflavin-specific RNA aptamer as a regulatory site. We constructed six variants with a series of base pairs in the linker region (stem II). Under single turnover conditions, kinetic studies were carried out in the absence and presence of flavin mononucleotide (FMN). Interestingly, FMN addition did not influence the cleavage rate of constructs with a 5-6 bp linker but stimulated the catalytic activity of those bearing a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
50
0

Year Published

1999
1999
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 107 publications
(50 citation statements)
references
References 26 publications
0
50
0
Order By: Relevance
“…The reward for acquiring this capability is substantial, considering that many applications in medicine, industry, and biotechnology demand high-speed enzymes with precisely tailored catalytic functions. ''Modular rational design'' has proven to be an effective means for conferring additional chemical and kinetic complexity on existing protein (1)(2)(3)(4) and RNA enzymes (5)(6)(7)(8)(9). This engineering strategy takes advantage of the modular nature of many protein (10) and RNA subdomains (11)(12)(13), which can be judiciously integrated to form new multifunctional constructs.…”
mentioning
confidence: 99%
“…The reward for acquiring this capability is substantial, considering that many applications in medicine, industry, and biotechnology demand high-speed enzymes with precisely tailored catalytic functions. ''Modular rational design'' has proven to be an effective means for conferring additional chemical and kinetic complexity on existing protein (1)(2)(3)(4) and RNA enzymes (5)(6)(7)(8)(9). This engineering strategy takes advantage of the modular nature of many protein (10) and RNA subdomains (11)(12)(13), which can be judiciously integrated to form new multifunctional constructs.…”
mentioning
confidence: 99%
“…Allosteric regulation has been imposed onto the hammerhead (Kertsburg and Soukup 2002), HDV (Kertsburg and Soukup 2002), hairpin , Tetrahymena group I intron (Kertsburg and Soukup 2002), and X-motif ribozymes (Kertsburg and Soukup 2002). The activity-modulating ligands include ATP (Tang and Breaker 1997;Robertson and Ellington 2000), theophylline (Soukup and Breaker 1999a;Robertson and Ellington 2000;Soukup et al 2000), flavin mononucleotide (FMN; Araki et al 1998Araki et al , 2001Breaker 1999a, 1999b;Robertson and Ellington 2000), cyclic nucleotide monophosphates (cNMPs; Koizumi et al 1999), doxycycline (Piganeau et al 2000), 3-methylxanthine (Soukup et al 2000), and pefloxacin (Piganeau et al 2001), as well as various metal ions (Seetharaman et al 2001), oligonucleotides (Porta and Lizardi 1995;Kuwabara et al 1998;Robertson and Ellington 1999;Komatsu et al 2000), and several proteins Vaish et al 2002). Allosteric regulation has also been extended to DNA enzymes that are activated by ATP (Levy and Ellington 2002).…”
Section: Allosteric Ribozyme Sensors (Aptazymes) and General "Communimentioning
confidence: 99%
“…These latter artificial regulators are called allosteric ribozymes, or aptazymes. To date, several aptazymes have been constructed using hammerhead ribozyme for various types of ligands, including ATP (Tang and Breaker 1997), FMN (Araki et al 1998;Soukup and Breaker 1999a), theophylline (Soukup and Breaker 1999a;Wieland and Hartig 2008), cyclic nucleotide monophosphates (Koizumi et al 1999), and thiamine pyrophosphate (TPP) (Wieland et al 2009). These aptazymes have been used for a wide range of applications, such as 5 artificial gene regulation in vivo (Kumar et al 2009;Carothers et al 2011) and as biosensors in vitro (Breaker 2002;Hesselberth et al 2003;Ogawa and Maeda 2007).…”
Section: Introductionmentioning
confidence: 99%